Marker | Advanced cancer n= 161 | Controls (matched with advanced cases) n= 436 | Non-advanced cancer n= 213 |
---|---|---|---|
Total PSA (ng/ml) | 1.22 (0.67, 2.42) | 0.54 (0.36, 0.78) | 0.98 (0.61, 1.56) |
Free PSA (ng/ml) | 0.35 (0.22, 0.67) | 0.18 (0.12, 0.26) | 0.30 (0.19, 0.45) |
Complexed PSA (ng/ml) | 0.81 (0.41, 1.64) | 0.32 (0.20, 0.51) | 0.62 (0.38, 1.04) |
Free to total PSA ratio (%) | 29.0 (24.2, 33.7) | 32.7 (28.3, 37.2) | 30.5 (26.2, 33.7) |
Human kallikrein 2 (ng/ml) | 0.039 (0.027, 0.055) | 0.033 (0.023, 0.044) | 0.037 (0.028, 0.053) |